Literature DB >> 23546386

Different adaptations in AMPA receptor transmission in the nucleus accumbens after short vs long access cocaine self-administration regimens.

Anthony Purgianto1, Andrew F Scheyer, Jessica A Loweth, Kerstin A Ford, Kuei Y Tseng, Marina E Wolf.   

Abstract

Ca(2+)-permeable AMPA receptors (CP-AMPARs) accumulate in the nucleus accumbens (NAc) after ∼1 month of withdrawal from a long-access cocaine self-administration regimen (6 h/d, 10d). This is functionally significant because CP-AMPARs mediate the 'incubated' cue-induced cocaine craving produced by this regimen. Our present goal was to determine if other commonly employed cocaine self-administration regimens also elicit CP-AMPAR accumulation. We compared four regimens, named according to whether sessions were short-access (ShA, 2 h) or long-access (LgA, 6 h) and the total number of sessions: LgA/10d (already shown to elicit CP-AMPAR accumulation), ShA/11d, ShA/20-24d, and LgA/20-24d. In the latter regimens, rats began with 10 days of ShA and then entered a differential phase (10-14 days) in which ShA sessions either continued or switched to LgA. Controls self-administered saline. After >40 days of withdrawal, whole-cell patch-clamp recordings were performed in NAc core medium spiny neurons to assess the contribution of CP-AMPAR transmission, based on the magnitude of synaptic suppression elicited by bath application of the selective CP-AMPAR antagonist naspm (100 μM). Naspm produced a non-significant (∼10%) attenuation of electrically evoked local excitatory postsynaptic current in the saline and ShA groups. By contrast, a significant naspm-induced synaptic attenuation (25-30%) was observed in both the LgA groups. Further analyses indicate that this emergence of CP-AMPAR transmission in the LgA groups is associated with increased baseline responsiveness of MSN to excitatory drive. Together with data on cocaine infusions in each group, our results show that CP-AMPAR accumulation and enhanced glutamate transmission is associated with longer sessions (6 h), rather than the number of sessions or cocaine infusions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546386      PMCID: PMC3717554          DOI: 10.1038/npp.2013.78

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  42 in total

1.  Integrins modulate relapse to cocaine-seeking.

Authors:  Armina Wiggins; Rachel J Smith; Hao-Wei Shen; Peter W Kalivas
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

2.  Alterations in AMPA receptor subunits and TARPs in the rat nucleus accumbens related to the formation of Ca²⁺-permeable AMPA receptors during the incubation of cocaine craving.

Authors:  Carrie R Ferrario; Jessica A Loweth; Mike Milovanovic; Kerstin A Ford; Gregorio L Galiñanes; Li-Jun Heng; Kuei Y Tseng; Marina E Wolf
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

3.  Increased motivation for self-administered cocaine after escalated cocaine intake.

Authors:  Neil E Paterson; Athina Markou
Journal:  Neuroreport       Date:  2003-12-02       Impact factor: 1.837

4.  Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area.

Authors:  Manuel Mameli; Camilla Bellone; Matthew T C Brown; Christian Lüscher
Journal:  Nat Neurosci       Date:  2011-02-20       Impact factor: 24.884

5.  Quantitative analysis of AMPA receptor subunit composition in addiction-related brain regions.

Authors:  Jeremy M Reimers; Michael Milovanovic; Marina E Wolf
Journal:  Brain Res       Date:  2010-10-11       Impact factor: 3.252

6.  Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc.

Authors:  Manuel Mameli; Briac Halbout; Cyril Creton; David Engblom; Jan Rodriguez Parkitna; Rainer Spanagel; Christian Lüscher
Journal:  Nat Neurosci       Date:  2009-07-13       Impact factor: 24.884

Review 7.  Using metabotropic glutamate receptors to modulate cocaine's synaptic and behavioral effects: mGluR1 finds a niche.

Authors:  Jessica A Loweth; Kuei Y Tseng; Marina E Wolf
Journal:  Curr Opin Neurobiol       Date:  2013-02-04       Impact factor: 6.627

8.  Evidence for addiction-like behavior in the rat.

Authors:  Véronique Deroche-Gamonet; David Belin; Pier Vincenzo Piazza
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

9.  The role of glutamate receptor redistribution in locomotor sensitization to cocaine.

Authors:  Carrie R Ferrario; Xuan Li; Xiaoting Wang; Jeremy M Reimers; Jamie L Uejima; Marina E Wolf
Journal:  Neuropsychopharmacology       Date:  2009-11-18       Impact factor: 7.853

Review 10.  Incubation of cocaine craving after withdrawal: a review of preclinical data.

Authors:  Lin Lu; Jeffrey W Grimm; Bruce T Hope; Yavin Shaham
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

View more
  46 in total

1.  A-Kinase Anchoring Protein 150 (AKAP150) Promotes Cocaine Reinstatement by Increasing AMPA Receptor Transmission in the Accumbens Shell.

Authors:  Leonardo A Guercio; Mackenzie E Hofmann; Sarah E Swinford-Jackson; Julia S Sigman; Mathieu E Wimmer; Mark L Dell'Acqua; Heath D Schmidt; R Christopher Pierce
Journal:  Neuropsychopharmacology       Date:  2017-12-12       Impact factor: 7.853

2.  Disruption of glutamate receptor-interacting protein in nucleus accumbens enhances vulnerability to cocaine relapse.

Authors:  Lisa A Briand; Blake A Kimmey; Pavel I Ortinski; Richard L Huganir; R Christopher Pierce
Journal:  Neuropsychopharmacology       Date:  2013-10-15       Impact factor: 7.853

Review 3.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

4.  Genetic loss of GluN2B in D1-expressing cell types enhances long-term cocaine reward and potentiation of thalamo-accumbens synapses.

Authors:  Max E Joffe; Brandon D Turner; Eric Delpire; Brad A Grueter
Journal:  Neuropsychopharmacology       Date:  2018-06-25       Impact factor: 7.853

5.  Synaptic Depotentiation and mGluR5 Activity in the Nucleus Accumbens Drive Cocaine-Primed Reinstatement of Place Preference.

Authors:  Michael A Benneyworth; Matthew C Hearing; Anders J Asp; Aric Madayag; Anna E Ingebretson; Clare E Schmidt; Keelia A Silvis; Erin B Larson; Stephanie R Ebner; Mark J Thomas
Journal:  J Neurosci       Date:  2019-04-04       Impact factor: 6.167

Review 6.  Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction.

Authors:  Natalie A Hadad; Lori A Knackstedt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-06       Impact factor: 4.530

7.  Neuroadaptations in the dorsal hippocampus underlie cocaine seeking during prolonged abstinence.

Authors:  Craig T Werner; Swarup Mitra; Benjamin D Auerbach; Zi-Jun Wang; Jennifer A Martin; Andrew F Stewart; Pedro H Gobira; Madoka Iida; Chunna An; Moriah M Cobb; Aaron Caccamise; Richard J Salvi; Rachael L Neve; Amy M Gancarz; David M Dietz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-05       Impact factor: 11.205

8.  A protein synthesis-dependent mechanism sustains calcium-permeable AMPA receptor transmission in nucleus accumbens synapses during withdrawal from cocaine self-administration.

Authors:  Andrew F Scheyer; Marina E Wolf; Kuei Y Tseng
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

9.  Disrupting GluA2 phosphorylation potentiates reinstatement of cocaine seeking.

Authors:  Lisa A Briand; Andre U Deutschmann; Alexandra S Ellis; Anne Q Fosnocht
Journal:  Neuropharmacology       Date:  2016-09-10       Impact factor: 5.250

10.  Prolonged withdrawal from cocaine self-administration affects prefrontal cortex- and basolateral amygdala-nucleus accumbens core circuits but not accumbens GABAergic local interneurons.

Authors:  Anthony Purgianto; Michael E Weinfeld; Marina E Wolf
Journal:  Addict Biol       Date:  2016-07-25       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.